Compare Illinois Tool Works Inc. (ITW) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs Johnson & Johnson — how do they compare? Illinois Tool Works Inc. trades at $264.13 (market cap $74.38B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 8.3× Illinois Tool Works Inc.'s market cap, and Illinois Tool Works Inc. pays the higher dividend (2.63%). Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 67 Days and Johnson & Johnson for 129 Days on average.
| ITW | JNJ | |
|---|---|---|
Market Cap | $74.38B | $618.09B |
Volume | 1,125,477 | 6,050,983 |
Sector | Industrials | Health |
52-Week High | $299.60 | $278.43 |
52-Week Low | $241.07 | $186.00 |
Typical Hold Time | 67 Days | 129 Days |
Enterprise Value | $83.23B | $646.37B |
Dividend Yield | 2.63% | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ITW trades at $264.71, up 1.36% today, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $2.84, beating estimates, and maintains robust profitability with a 19.39% net income margin and 104.65% ROE. Recent news highlights its dividend increase to $1.72 per share and its status as a Dividend King with 59 years of consecutive increases.
The outlook is mixed: strong cash flow and dividend reliability support income investors, but high valuation ratios (P/E 23.65, P/B 25.7) and bearish technicals suggest near-term pressure. Risks include debt levels and sector volatility, while analyst consensus leans hold with a $276.86 price target.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).
JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
